drugset / Trial / NCT00703859

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

NCT00703859

Phase 1 Withdrawn AHS Cancer Control Alberta
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study to see whether radiotherapy plus chemotherapy (Temozolomide) plus Dichloroacetate (DCA) improves overall survival and offers better control of the disease in patients with newly diagnosed Glioblastoma Multiforme Tumours.

Timeline

Start
2008-07
Primary completion
2010-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dichloroacetate Small molecule 3 mg/kg Oral

Indications